FDA To Seek More Power Over Compounders At Hearing
The U.S. Food and Drug Administration will make the case to Congress on Wednesday that it should have more authority over compounding pharmacies, but it is likely to be met with...To view the full article, register now.
Already a subscriber? Click here to view full article